» Articles » PMID: 27768061

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Overview
Journal J Vis Exp
Date 2016 Oct 22
PMID 27768061
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Human signal transducer and activator of transcription 3 (STAT3) is one of many genes containing a tandem splicing site. Alternative donor splice sites 3 nucleotides apart result in either the inclusion (S) or exclusion (ΔS) of a single residue, Serine-701. Further downstream, splicing at a pair of alternative acceptor splice sites result in transcripts encoding either the 55 terminal residues of the transactivation domain (α) or a truncated transactivation domain with 7 unique residues (β). As outlined in this manuscript, measuring the proportions of STAT3's four spliced transcripts (Sα, Sβ, ΔSα and ΔSβ) was possible using absolute qPCR (quantitative polymerase chain reaction). The protocol therefore distinguishes and measures highly similar splice variants. Absolute qPCR makes use of calibrator plasmids and thus specificity of detection is not compromised for the sake of efficiency. The protocol necessitates primer validation and optimization of cycling parameters. A combination of absolute qPCR and efficiency-dependent relative qPCR of total STAT3 transcripts allowed a description of the fluctuations of STAT3 splice variants' levels in eosinophils treated with cytokines. The protocol also provided evidence of a co-splicing interdependence between the two STAT3 splicing events. The strategy based on a combination of the two qPCR techniques should be readily adaptable to investigation of co-splicing at other tandem splicing sites.

Citing Articles

Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi-allelic isoform-specific start-loss mutations of essential genes can cause genetic diseases.

Perenthaler E, Nikoncuk A, Yousefi S, Berdowski W, Alsagob M, capo I Acta Neuropathol. 2019; 139(3):415-442.

PMID: 31820119 PMC: 7035241. DOI: 10.1007/s00401-019-02109-6.

References
1.
Wang M, Zhang P, Shu Y, Yuan F, Zhang Y, Zhou Y . Alternative splicing at GYNNGY 5' splice sites: more noise, less regulation. Nucleic Acids Res. 2014; 42(22):13969-80. PMC: 4267661. DOI: 10.1093/nar/gku1253. View

2.
Stahl N, Farruggella T, Boulton T, Zhong Z, Darnell Jr J, Yancopoulos G . Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science. 1995; 267(5202):1349-53. DOI: 10.1126/science.7871433. View

3.
Zheng M, Turton K, Zhu F, Li Y, Grindle K, Annis D . A mix of S and ΔS variants of STAT3 enable survival of activated B-cell-like diffuse large B-cell lymphoma cells in culture. Oncogenesis. 2016; 4:e184. PMC: 4728674. DOI: 10.1038/oncsis.2015.44. View

4.
Narimatsu M, Maeda H, Itoh S, Atsumi T, Ohtani T, Nishida K . Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells. Mol Cell Biol. 2001; 21(19):6615-25. PMC: 99807. DOI: 10.1128/MCB.21.19.6615-6625.2001. View

5.
Zhang H, Lai R . STAT3 in Cancer-Friend or Foe?. Cancers (Basel). 2014; 6(3):1408-40. PMC: 4190548. DOI: 10.3390/cancers6031408. View